These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 9046951)
1. RU486 (mifepristone): mechanisms of action and clinical uses. Cadepond F; Ulmann A; Baulieu EE Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951 [TBL] [Abstract][Full Text] [Related]
2. RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996. Baulieu EE Ann N Y Acad Sci; 1997 Sep; 828():47-58. PubMed ID: 9329823 [TBL] [Abstract][Full Text] [Related]
3. Antiprogestins: mechanism of action and contraceptive potential. Spitz IM; Croxatto HB; Robbins A Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382 [TBL] [Abstract][Full Text] [Related]
4. Mifepristone (RU486): a review. Mahajan DK; London SN Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681 [TBL] [Abstract][Full Text] [Related]
5. RU486: a compound that gets itself talked about. Baulieu EE Hum Reprod; 1994 Jun; 9 Suppl 1():1-6. PubMed ID: 7962455 [TBL] [Abstract][Full Text] [Related]
6. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013 [TBL] [Abstract][Full Text] [Related]
7. Fertility control in women: results with RU 486 by the end of 1985. Baulieu E J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366 [TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review. Healy DL Reprod Fertil Dev; 1990; 2(5):477-90. PubMed ID: 1963697 [TBL] [Abstract][Full Text] [Related]
9. Approval of mifepristone (RU 486) in Europe. Sitruk-Ware R Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210 [TBL] [Abstract][Full Text] [Related]
10. History and perspectives of antiprogestins from the chemist's point of view. Teutsch G; Philibert D Hum Reprod; 1994 Jun; 9 Suppl 1():12-31. PubMed ID: 7962457 [TBL] [Abstract][Full Text] [Related]
11. The use of anti-progesterones as a medical IUD. Nieman LK; Loriaux DL Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821 [TBL] [Abstract][Full Text] [Related]
12. Contraception by the progesterone antagonist RU 486: a novel approach to human fertility control. Baulieu EE Res Reprod; 1987 Jan; 19(1):3-4. PubMed ID: 12314576 [TBL] [Abstract][Full Text] [Related]
13. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications. Baulieu EE Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181 [TBL] [Abstract][Full Text] [Related]
14. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses. Frydman R; Fernandez H; Pons JC; Ulmann A Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355 [TBL] [Abstract][Full Text] [Related]
15. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486. Baulieu EE Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651 [TBL] [Abstract][Full Text] [Related]
16. [Multiple usages for antiprogestins]. Heikinheimo O Duodecim; 1994; 110(10):1001-8. PubMed ID: 7588093 [No Abstract] [Full Text] [Related]
18. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium. Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418 [TBL] [Abstract][Full Text] [Related]
19. Early pregnancy termination with mifepristone and misoprostol in the United States. Spitz IM; Bardin CW; Benton L; Robbins A N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577 [TBL] [Abstract][Full Text] [Related]